Searchable abstracts of presentations at key conferences in endocrinology

ea0077oc6.3 | Thyroid | SFEBES2021

Failure of Radioiodine Remnant Ablation to Improve Postoperative Outcome in 2668 Adult Patients with AJCC/pTNM Stage I Papillary Thyroid Carcinoma

Hay Ian , Kaggal Suneetha , Mullan Brian , Thompson Geoffrey

Background: To determine whether radioiodine remnant ablation (RRA) reduces cause-specific mortality (CSM) or tumor recurrence (TR) rates after bilateral thyroidectomy (BT) in low-risk adult papillary thyroid carcinoma (APTC) patients treated with curative intent, we compared outcome in 1836 stage I patients having BT alone with 832 having BT+RRA.Methods: THEN cohort (1966-1990) comprised 809 patients; 36% having RRA within 6 postoperative months. NOW co...

ea0084op-09-42 | Oral Session 9: Thyroid Cancer Clinical | ETA2022

Childhood papillary thyroid carcinoma: long-term postoperative outcome and prediction of recurrent disease in 189 patients consecutively treated at the mayo clinic during 1936 through 2020

Hay Ian , Kaggal Suneetha , Rivera Michael , Pittock Siobhan , Thompson Geoffrey

Objectives: Childhood papillary thyroid cancer (CPTC) often presents with advanced disease but rarely results in cause-specific mortality (CSM). Controversy remains regarding optimal management and association with non-thyroid second primary malignancies (NSPM). We analyzed outcome in 189 CPTC patients and assessed the influence of radioiodine remnant ablation (RRA) and the utility of the American Thyroid Association risk-groups (ATA-R) in predicting tumor recurrence (TR)....